olmesartan medoxomil has been researched along with Long QT Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, J; Matsushima, N; Mendell, J; Song, S | 1 |
| Lee, J; Matsushima, N; Mendell, J; O'Reilly, TE | 1 |
2 trial(s) available for olmesartan medoxomil and Long QT Syndrome
| Article | Year |
|---|---|
Linear mixed-effects model of QTc prolongation for olmesartan medoxomil.
Topics: Adult; Antihypertensive Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Linear Models; Long QT Syndrome; Male; Middle Aged; Models, Biological; Olmesartan Medoxomil; Young Adult | 2016 |
A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval.
Topics: Adolescent; Adult; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography; Female; Healthy Volunteers; Heart; Humans; Long QT Syndrome; Male; Middle Aged; Olmesartan Medoxomil; Young Adult | 2016 |